The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension

Heart

Volumn 91, Issue 2, 2005, Pages 241-242

  Le Roux, C W ^a   Ghatei, M A ^a   Gibbs, J S R ^a   Bloom, Stephen R ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BOSENTAN; CANDESARTAN; DIGOXIN; FUROSEMIDE; GHRELIN; ILOPROST; MONTELUKAST; PEPTIDE YY; RAMIPRIL; SPIRONOLACTONE; UNIPROST; WARFARIN;

ADULT; ANOREXIA; ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; BODY MASS; CACHEXIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART CACHEXIA; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SATIETY; WEIGHT REDUCTION;

ADULT; APPETITE; CACHEXIA; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION, PULMONARY; MALE; PEPTIDE HORMONES; PEPTIDE YY; POSTPRANDIAL PERIOD; SATIATION;

EID: 12744253686     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.026880     Document Type: Article

References (5)

1. Anker SD, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003;361:1077-83.
2. Pittman J, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med 1964;271:403-8.
3. Nagaya N, Uematsu M, Kojima M, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 2001;104:2034-8.
4. Batterham RL, Cowley AM, Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002;418:650-4.
5. Hill JO, Wyatt HR, Reed GW, et al. Obesity and the environment: where do we go from here? Science 2003;299:853-5.